APDN250117C2500
- 0.05
- 0.000.00%
Applied DNA Sciences Newsroom
Express News | Applied Dna Sciences Announced That It Has Rescheduled Its Investor Update Call To Thursday, February 13, 2025
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced From Linea DNA
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday
10-K: FY2024 Annual Report
Applied DNA Sciences Announces Leadership Changes and Restructuring
Applied DNA Sciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Sales Results and Announced Plans for a Strategic Restructuring of Operations Including Divestiture of Certain Business Segments.
Express News | Applied DNA Sciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Sales Results and Announced Plans for a Strategic Restructuring of Operations Including Divestiture of Certain Business Segments
8-K: Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
Express News | Applied DNA Reveals Immediate Promotion Of COO Judith Murrah To President; James Hayward Remains Chairman Of Board And CEO
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot
Express News | Applied DNA Sciences Inc - Targeting of Operating Expense Reductions of 15% Compared to Fiscal 2024
Express News | Applied DNA Sciences Inc - Net Loss for Q4 of Fiscal 2024 Was $0.32 per Share
Express News | Applied DNA Sciences Inc - Pursuing Divestiture of Certaint Platform, Implements Changes to Corporate Leadership
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q4 Revenue $813,106, Vs. Street Est of $0.9M
Earnings Scheduled For December 17, 2024
Earnings Preview: APDN to Report Financial Results Post-market on December 17
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide With Update on GMP Manufacturing Facility Build-out
WHO Extends Mpox Emergency; Canada Reports First Clade I Case